DOI QR코드

DOI QR Code

The follow-up study on patients of Amyotrophic lateral sclerosis after 1 year

근위축성 측삭경화증 환자 1년 후 추적 조사

  • Kim, Hyun-Sik (Dept. of Internal Medicine, Gwang-Ju Oriental Medical Hospital, Wonkwang University) ;
  • Song, Bong-Kuen (Dept. of Internal Medicine, Gwang-Ju Oriental Medical Hospital, Wonkwang University) ;
  • Park, Man-Yong (Dept. of Acupuncture & Moxibustion, Gwang-Ju Oriental Medical Hospital, Wonkwang University) ;
  • Lim, Na-Ra (Dept. of Acupuncture & Moxibustion, Gwang-Ju Oriental Medical Hospital, Wonkwang University) ;
  • Kim, Sung-Ha (Dept. of Acupuncture & Moxibustion, Gwang-Ju Oriental Medical Hospital, Wonkwang University) ;
  • Kim, Sung-Chul (Dept. of Acupuncture & Moxibustion, Gwang-Ju Oriental Medical Hospital, Wonkwang University)
  • 김현식 (원광대학교 광주 한방병원 한방내과) ;
  • 송봉근 (원광대학교 광주 한방병원 한방내과) ;
  • 박만용 (원광대학교 광주 한방병원 침구과) ;
  • 임나라 (원광대학교 광주 한방병원 침구과) ;
  • 김성하 (원광대학교 광주 한방병원 침구과) ;
  • 김성철 (원광대학교 광주 한방병원 침구과)
  • Published : 2010.03.31

Abstract

Objectives : This study was to investigate the effects of Oriental medical treatment on ALS. Methods : We investigated 12 ALS patients which were admitted to Gwang-Ju O.M.hospital for 3 months and follow-up at 8 months after discharge. All patients were treated by SAAM-acupuncture, herb medication, Bee venom Pharmacopuncture therapy, Needle-embedding therapy, etc and after discharge self-therapy at home. We evaluated patients using the Amyotrophic lateral sclerosis Functional Rating Scale-Revised(ALSFRS-R), Medical Research Council (MRC) Scale. Results : After 1 month, mean ALSFRS-R score of patients was $29.08{\pm}7.99$, 2 months $28.70{\pm}7.17$, 3 months $28.16{\pm}8.23$, 1 year $21.33{\pm}9.93$ and mean MRC Scale of patients was $25.34{\pm}8.45$, 2 months $25.34{\pm}8.45$, 3months $21.56{\pm}9.20$. But in both cases, the variation was not statistically significant. Conclusions : We think that the results of this case be a pilot study that proves the effect of Oriental Medical treatment on ALS.

Keywords

References

  1. Williams DB, Windebank AJ. Motor neuron disease(amyotrophic lateral sclerosis). Mayo Clin Proc 1991;66:54-82 https://doi.org/10.1016/S0025-6196(12)61175-6
  2. Caroscio JT, Mulvihill MN, Sterling R, et al. Amyotrophic lateral sclerosis its natural history. Neurol Clin. 1987;5:1-9
  3. Kim SH. Diagnosis and therapeutic strategies of amyotrophic lateral sclerosis. Hanyang medical reviews. 2006;26(1):44-51
  4. Traynor BJ, Alexander M, Corr B, et al. An outcome study of riluzole in amyotrophic lateral sclerosis. A population based study in Ireland, 1996-2000. Journal of Neurology. 2003;250:473-479 https://doi.org/10.1007/s00415-003-1026-z
  5. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-299 https://doi.org/10.1080/146608200300079536
  6. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol. 1996;53:141-147 https://doi.org/10.1001/archneur.1996.00550020045014
  7. Na Won-min. The clinical study on 12 cases of patients of Amyotrophic lateral sclerosis. Journal of Korean pharmacopuncture Institute. 2009.3.vol 12 (1):53-65 https://doi.org/10.3831/KPI.2009.12.1.053
  8. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic lateral sclerosis. Philadelphia: F. A. Davis Company. 1998:3-33, 151-163
  9. Jokelainen M. Amyotrophic lateral sclerosis in Finland; 1. an epidemiological study; 2. clinical characteristics. Acta Neurol Scand. 1977;56:185-193,194-204 https://doi.org/10.1111/j.1600-0404.1977.tb01424.x

Cited by

  1. A Literature Review of Korean Medical Studies of Amyotrophic Lateral Sclerosis (ALS) vol.32, pp.4, 2015, https://doi.org/10.13045/acupunct.2015068
  2. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial vol.19, pp.1, 2018, https://doi.org/10.1186/s13063-018-2557-z